CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Sale | −166,696 | $26.53 | $4.4M | 22,963 |
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise · Stock Option (Right to Buy) | −106,696 | 0 | ||
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +37,500 | $1.20 | $45K | 37,500 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +50,000 | $0.92 | $46K | 87,500 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +1,500 | $5.64 | $8K | 89,000 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +1,500 | $5.57 | $8K | 90,500 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +1,500 | $4.90 | $7K | 92,000 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +1,500 | $5.66 | $8K | 93,500 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +1,500 | $6.11 | $9K | 95,000 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise | +50,000 | $2.96 | $148K | 145,000 |
| 2021-05-21 | FAVUS ELLIOT Director | Sale | −145,000 | $11.70 | $1.7M | 0 |
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −37,500 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 |
Page 5 of 12 · 232 trades